Abstract
We developed self-emulsifying water-in-oil (w/o) microemulsions incorporating medium-chain glycerides and measured their conductance, viscosity, refractive index and particle size. Formulation of Calcein (a water-soluble marker molecule, MW = 623), or SK&F 106760 (a water-soluble RGD peptide, MW = 634) in a w/o microemulsion having a composition of Captex 355/Capmul MCM/Tween 80/Aqueous (65/22/10/3, % w/w), resulted in significant bioavailabil-ity enhancement in rats relative to their aqueous formulations. Upon intraduodenal administration the bioavailability was enhanced from 2% for Calcein in isotonic Tris, pH 7.4 to 45% in the microemulsion and from 0.5% for SK&F 106760 in physiological saline to 27% in the microemulsion formulation. The microemulsion did not induce gross changes in GI mucosa at a dosing volume of 3.3 ml/kg. These results suggest that water-in-oil microemulsion systems may be utilized for enhancement of intestinal drug absorption.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
W. A. Ritschel. Microemulsions for improved peptide absorption from the gastrointestinal tract. Meth. Find. Exp. Clin. Pharmacol. 13:205–220 (1993).
H. N. Bhargava, A. Narurkar, and L. M. Lieb. Using microemulsions for drug delivery. Pharm. Technol. 11(3):46–52, 1987.
R. Leung, and Shah, D. O. Microemulsions: An evolving technology for pharmaceutical applications. In: M. Rosoff (ed). Controlled Release of Drugs: Polymers and Aggregate Systems. VCH Publishers, New York (1989) pp. 185–215.
D. W. Osborne, C. A. Middleton, and R. L. Rogers. Alcoholfree microemulsions. J. Dispersion Sci. Technol. 9:415–423 (1988).
E. C. Swenson and W. J. Curatolo. Intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity. Adv. Drug Deliv. Rev. 8:39–92, (1992).
P. P. Constantinides. Water-in-oil Microemulsions. PCT Publication WO 93/02664, 18 February 1993.
S. Muranishi. Absorption Enhancers. Crit. Rev. Ther. Drug Carrier Syst. 7:1–33 (1990).
E. J. Van Hoogdalem, M. A. Hardens, A. G. De Boer, and D. D. Breimer. Absorption enhancement of rectally infused cefoxitin sodium by medium-chain fatty acids in conscious rats: Concentration-Effect relationship. Pharm. Res. 5:453–456, (1988).
K. Nishimura, Y. Nozaki, A. Yoshimi, S. Nakamura, M. Kitagawa, N. Kakeya, and K. Kitao. Studies on the promoting effects of carboxylic acid derivatives on the rectal absorption of beta-lactam antibiotics in rats. Chem. Pharm. Bull. 33:282–291 (1985).
E. J. Van Hoogdalem, A. G. De Boer, and D. D. Breimer. Rectal absorption enhancement of rate-controlled delivered ampicillin sodium by sodium decanoate in conscious rats. Pharm. Weekbl. Sci. 10:76–79 (1988).
M. Sekine, K. Sasahara, T. Kojima, K. Hasegawa, and R. Okada. Improvement of bioavailability of poorly intestinally absorbed drugs from medium-chain glyceride base: Enhancement of the rectal absorption of cefmetazole sodium in rabbits. Chem. Pharm. Bull. 32:4189–4192 (1984).
M. Sekine, K. Sasahara, T. Kojima, K. Hasegawa, R. Okada, and S. Awazu. Improvement of bioavailability of poorly absorbed drugs. I. Effect of medium-chain glyceride base on the rectal absorption of Cefmetazole sodium in rats. J. Pharmacobio-Dyn. 7:856–863 (1984).
M. Sekine, K. Sasahara, R. Okada, and S. Awazu. Improvement of bioavailability of poorly absorbed drugs. IV. Mechanism of the promoting effect of medium-chain glyceride on the rectal absorption of water soluble drugs. J. Pharmacobio-Dyn. 8:645–652 (1985).
G. Beskid, J. Unowsky, C. R. Behl, J. Siebelist, J. L. Tossounian, C. M. McGarry, N. H. Shah, and R. Cleeland. Enteral, oral and rectal absorption of Ceftriaxone using glyceride enhancers. Chemother. 34:77–84 (1988).
K. J. Palin, A. J. Phillips, and A. Ning. The oral absorption of Cefoxitin from oil and emulsion vesicles in rats. Int. J. Pharm. 33:99–104 (1986).
B. Hauser, A. Meinzer, U. Posanski, and F. Richter. Cyclosporin Emulsion Composition. GB Patent Application 2, 222, 770, 21 March, 1990.
J. Samanen, F. Ali, T. Romoff, R. Calvo, E. Sorenson, J. Vasko, B. Storer, D. Berry, D. Bennett, M. Strohsacker, D. Powers, J. Stadel, and A. Nichols. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro. Med. Chem. 34:3114–3125 (1991).
G. R. Rhodes and V. K. Boppana. High performance liquid chromatographic analysis of arginine-containing peptides in biological fluids by means of a selective post-column reaction with fluorescence detection. J. Chromatography 444:123–131 (1988).
R. A. Myers and V. J. Stella. Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int. J. Pharm. 78:217–226 (1992).
T. T. Kararli, T. E. Needham, M. Griffin, G. Schoenhard, L. J. Ferro, and L. Alcorn. Oral delivery of a renin inhibitor compound using emulsion formulations. Pharm. Res. 9(7):888–893 (1992).
A. B. Steffans. A method for frequent sampling of blood and continuous infusion of fluids in the rat without disturbing the animal. Physiol. Behav. 4:833–836 (1969).
V. H. L. Lee, A. Yamamoto, and U. B. Kompella. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit. Rev. Ther. Drug Carrier Syst. 8(2):91–192 (1991).
P.-Y. Yeh, P. L. Smith, and H. Ellens. Effect of medium-chain glycerides on physiology of intestinal epithelium in vitro. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 20:176–177 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Constantinides, P.P., Scalart, JP., Lancaster, C. et al. Formulation and Intestinal Absorption Enhancement Evaluation of Water-in-Oil Microemulsions Incorporating Medium-Chain Glycerides. Pharm Res 11, 1385–1390 (1994). https://doi.org/10.1023/A:1018927402875
Issue Date:
DOI: https://doi.org/10.1023/A:1018927402875